• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部非黑色素瘤皮肤癌中的巨噬细胞和T细胞浸润以及免疫细胞的拓扑分布

Macrophage and T-Cell Infiltration and Topographic Immune Cell Distribution in Non-Melanoma Skin Cancer of the Head and Neck.

作者信息

Frohwitter Gesche, Kerta Marie, Vogl Christoph, Geppert Carol Immanuel, Werry Jan-Erik, Ries Jutta, Kesting Marco, Weber Manuel

机构信息

Department for Oral and Maxillofacial Surgery, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Bavaria, Germany.

Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Bavaria, Germany.

出版信息

Front Oncol. 2022 Apr 7;12:809687. doi: 10.3389/fonc.2022.809687. eCollection 2022.

DOI:10.3389/fonc.2022.809687
PMID:35463364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9022069/
Abstract

Non-melanoma skin cancer (NMSC) is a heterogeneous tumor entity that is vastly determined by age and UV-light exposure leading to a great mutational burden in cancer cells. However, the success of immune checkpoint blockade in advanced NMSC and the incidence and disease control rates of NMSC in organ transplant recipients compared to immunologically uncompromised patients point toward the emerging importance of the immunologic activity of NMSC. To gain first insight into the role of T-cell and macrophage infiltration in NMSC of the head and neck and capture their different immunogenic profiles, which appear to be highly relevant for the response to immunotherapy, we conducted a whole slide analysis of 107 basal cell carcinoma (BCC) samples and 117 cutaneous squamous cell carcinoma (cSCC) samples. The CD8 and CD68 immune cell expression in both cancer types was evaluated by immunohistochemistry and a topographic distribution profile, and the proportion of both cell populations within the two tumor entities was assessed. The results show highly significant differences in terms of CD8 T-cell and CD68 macrophage infiltration in BCC and cSCC and indicate cSCC as a highly immunogenic tumor. Yet, BCC presents less immune cell infiltration; the relation between the immune cells compared to cSCC does not show any significant difference. These findings help explain disparities in local aggressiveness, distant metastasis, and eligibility for immune checkpoint blockade in both tumor entities and encourage further research.

摘要

非黑色素瘤皮肤癌(NMSC)是一种异质性肿瘤实体,其很大程度上由年龄和紫外线暴露决定,导致癌细胞中存在巨大的突变负担。然而,晚期NMSC中免疫检查点阻断的成功,以及与免疫功能正常的患者相比,器官移植受者中NMSC的发病率和疾病控制率,都表明NMSC免疫活性的重要性日益凸显。为了初步了解T细胞和巨噬细胞浸润在头颈部NMSC中的作用,并捕捉它们不同的免疫原性特征,这似乎与免疫治疗反应高度相关,我们对107份基底细胞癌(BCC)样本和117份皮肤鳞状细胞癌(cSCC)样本进行了全玻片分析。通过免疫组织化学和地形图分布分析评估了两种癌症类型中CD8和CD68免疫细胞的表达,并评估了这两种细胞群体在两个肿瘤实体中的比例。结果显示,BCC和cSCC在CD8 T细胞和CD68巨噬细胞浸润方面存在高度显著差异,表明cSCC是一种高度免疫原性肿瘤。然而,BCC的免疫细胞浸润较少;与cSCC相比,免疫细胞之间的关系没有显示出任何显著差异。这些发现有助于解释这两种肿瘤实体在局部侵袭性、远处转移和免疫检查点阻断适用性方面的差异,并鼓励进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb0/9022069/0c09cfc15ecf/fonc-12-809687-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb0/9022069/ace39c162c88/fonc-12-809687-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb0/9022069/59c7c55083c5/fonc-12-809687-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb0/9022069/5572a1fe454d/fonc-12-809687-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb0/9022069/a8ecf6f2ee79/fonc-12-809687-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb0/9022069/ddc10a2851c2/fonc-12-809687-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb0/9022069/0c09cfc15ecf/fonc-12-809687-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb0/9022069/ace39c162c88/fonc-12-809687-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb0/9022069/59c7c55083c5/fonc-12-809687-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb0/9022069/5572a1fe454d/fonc-12-809687-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb0/9022069/a8ecf6f2ee79/fonc-12-809687-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb0/9022069/ddc10a2851c2/fonc-12-809687-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb0/9022069/0c09cfc15ecf/fonc-12-809687-g006.jpg

相似文献

1
Macrophage and T-Cell Infiltration and Topographic Immune Cell Distribution in Non-Melanoma Skin Cancer of the Head and Neck.头颈部非黑色素瘤皮肤癌中的巨噬细胞和T细胞浸润以及免疫细胞的拓扑分布
Front Oncol. 2022 Apr 7;12:809687. doi: 10.3389/fonc.2022.809687. eCollection 2022.
2
Immune Checkpoints and Cellular Landscape of the Tumor Microenvironment in Non-Melanoma Skin Cancer (NMSC).非黑色素瘤皮肤癌(NMSC)中的肿瘤微环境免疫检查点和细胞景观。
Cells. 2024 Sep 26;13(19):1615. doi: 10.3390/cells13191615.
3
Evidence of Neutrophils and Neutrophil Extracellular Traps in Human NMSC with Regard to Clinical Risk Factors, Ulceration and CD8 T Cell Infiltrate.有关临床危险因素、溃疡和 CD8 T 细胞浸润的人类非黑色素瘤皮肤癌中的中性粒细胞和中性粒细胞细胞外陷阱的证据。
Int J Mol Sci. 2024 Oct 2;25(19):10620. doi: 10.3390/ijms251910620.
4
Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.非黑色素瘤皮肤癌:英国国家多学科指南
J Laryngol Otol. 2016 May;130(S2):S125-S132. doi: 10.1017/S0022215116000554.
5
Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current Evidence.非黑色素瘤皮肤癌中的免疫检查点抑制:当前证据综述
Front Oncol. 2021 Dec 20;11:734354. doi: 10.3389/fonc.2021.734354. eCollection 2021.
6
Towards less mutilating treatments in patients with advanced non-melanoma skin cancers by earlier use of immune checkpoint inhibitors.通过更早地使用免疫检查点抑制剂,减少晚期非黑色素瘤皮肤癌患者的破坏性治疗。
Crit Rev Oncol Hematol. 2022 Dec;180:103855. doi: 10.1016/j.critrevonc.2022.103855. Epub 2022 Oct 17.
7
Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.与免疫功能正常的患者相比,长期免疫抑制的实体器官移植受者的非黑素瘤皮肤癌中 p53 上调凋亡调节因子(PUMA)的表达。
Eur J Dermatol. 2021 Oct 1;31(5):609-615. doi: 10.1684/ejd.2021.4133.
8
Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report.晚期皮肤鳞状细胞癌对免疫疗法的反应:病例报告
Stem Cell Investig. 2021 Sep 6;8:19. doi: 10.21037/sci-2020-071. eCollection 2021.
9
Local immune response in cutaneous basal cell carcinoma.皮肤基底细胞癌中的局部免疫反应。
Dan Med J. 2017 Oct;64(10).
10
Risk factors for non-melanoma skin cancer development in renal transplant recipients: a 40 year retrospective study in Croatia.在克罗地亚进行的一项长达 40 年的回顾性研究:肾移植受者中非黑色素瘤皮肤癌发展的风险因素。
Croat Med J. 2022 Apr 30;63(2):148-155. doi: 10.3325/cmj.2022.63.148.

引用本文的文献

1
Identification and analysis of immune cell-related genes in cutaneous squamous cell carcinoma and drug network prediction.皮肤鳞状细胞癌中免疫细胞相关基因的鉴定与分析及药物网络预测
Arch Dermatol Res. 2024 Dec 30;317(1):158. doi: 10.1007/s00403-024-03587-9.
2
Evidence of Neutrophils and Neutrophil Extracellular Traps in Human NMSC with Regard to Clinical Risk Factors, Ulceration and CD8 T Cell Infiltrate.有关临床危险因素、溃疡和 CD8 T 细胞浸润的人类非黑色素瘤皮肤癌中的中性粒细胞和中性粒细胞细胞外陷阱的证据。
Int J Mol Sci. 2024 Oct 2;25(19):10620. doi: 10.3390/ijms251910620.
3
Comparative Analysis of Inhibitory and Activating Immune Checkpoints PD-1, PD-L1, CD28, and CD86 in Non-Melanoma Skin Cancer.

本文引用的文献

1
PD-L1 Expression, T-lymphocyte Subpopulations and Langerhans Cells in Cutaneous Squamous Cell Carcinoma and Precursor Lesions.PD-L1 表达、T 淋巴细胞亚群和朗格汉斯细胞在皮肤鳞状细胞癌及其前体病变中的表达。
Anticancer Res. 2021 Jul;41(7):3439-3448. doi: 10.21873/anticanres.15131.
2
Tumour budding in solid cancers.实体癌中的肿瘤芽生
Nat Rev Clin Oncol. 2021 Feb;18(2):101-115. doi: 10.1038/s41571-020-0422-y. Epub 2020 Sep 8.
3
Microenvironment in cutaneous melanomas: a gene expression profile study may explain the role of histological regression.
非黑色素瘤皮肤癌中抑制性和激活性免疫检查点 PD-1、PD-L1、CD28 和 CD86 的对比分析。
Cells. 2024 Sep 18;13(18):1569. doi: 10.3390/cells13181569.
4
Advanced Cutaneous Squamous Cell Carcinoma Management in Immunotherapy Era: Achievements and New Challenges.免疫治疗时代晚期皮肤鳞状细胞癌的管理:成就与新挑战
Dermatol Pract Concept. 2023 Oct 1;13(4):e2023251. doi: 10.5826/dpc.1304a251.
皮肤黑色素瘤中的微环境:一项基因表达谱研究或许能解释组织学消退的作用。
J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e35-e38. doi: 10.1111/jdv.16784. Epub 2020 Aug 4.
4
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.肿瘤微环境对免疫检查点阻断治疗的反应。
Front Immunol. 2020 May 7;11:784. doi: 10.3389/fimmu.2020.00784. eCollection 2020.
5
Immunologic Characteristics of Nonmelanoma Skin Cancers: Implications for Immunotherapy.非黑色素瘤皮肤癌的免疫特征:对免疫治疗的启示。
Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-10. doi: 10.1200/EDBK_278953.
6
Human keratinocyte carcinomas have distinct differences in their tumor-associated macrophages.人类角质形成细胞癌在其肿瘤相关巨噬细胞方面存在明显差异。
Heliyon. 2019 Aug 13;5(8):e02273. doi: 10.1016/j.heliyon.2019.e02273. eCollection 2019 Aug.
7
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study.纳武利尤单抗联合舒尼替尼或帕唑帕尼治疗晚期或转移性肾细胞癌的安全性和有效性:CheckMate 016 研究。
J Immunother Cancer. 2018 Oct 22;6(1):109. doi: 10.1186/s40425-018-0420-0.
8
Immunotherapy for Merkel Cell Carcinoma.默克尔细胞癌的免疫治疗。
Curr Treat Options Oncol. 2018 Sep 20;19(11):57. doi: 10.1007/s11864-018-0574-5.
9
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.西妥昔单抗联合 PD-1 抑制剂治疗晚期皮肤鳞状细胞癌的疗效和安全性
N Engl J Med. 2018 Jul 26;379(4):341-351. doi: 10.1056/NEJMoa1805131. Epub 2018 Jun 4.
10
T-lymphocyte profiles differ between keratoacanthomas and invasive squamous cell carcinomas of the human skin.T 淋巴细胞谱在人类皮肤的角化棘皮瘤和侵袭性鳞状细胞癌之间存在差异。
Cancer Immunol Immunother. 2018 Jul;67(7):1147-1157. doi: 10.1007/s00262-018-2171-7. Epub 2018 May 24.